VR

Vangipuram S. Rangan

BS Bristol-Myers Squibb: 5 patents #1,010 of 3,969Top 30%
ME Medarex: 1 patents #118 of 190Top 65%
ML Medarex, L.L.C.: 1 patents #19 of 67Top 30%
📍 Pleasant Hill, CA: #70 of 365 inventorsTop 20%
🗺 California: #82,707 of 386,348 inventorsTop 25%
Overall (All Time): #694,419 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12077584 Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A) Natalie Bezman, Alan J. Korman, Shrikant Deshpande, Amy D. Jhatakia, Richard Y. Huang +5 more 2024-09-03
11981734 Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A) Natalie Bezman, Alan J. Korman, Shrikant Deshpande, Amy D. Jhatakia, Richard Y. Huang +5 more 2024-05-14
11274150 Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies Natalie Bezman, Alan J. Korman, Shrikant Deshpande, Amy D. Jhatakia, Richard Y. Huang +5 more 2022-03-15
10279049 Antibody-drug conjugates of tubulysin analogs with enhanced stability Qiang Cong, Sanjeev Gangwar, Mei-Chen Sung 2019-05-07
9994633 IP-10 antibodies and their uses Shrikant Deshpande, Haichun Huang, Mohan Srinivasan, Josephine M. Cardarelli, Changyu Wang +4 more 2018-06-12
8945546 IP-10 antibodies and their uses Shrikant Deshpande, Haichun Huang, Mohan Srinivasan, Josephine M. Cardarelli, Changyu Wang +4 more 2015-02-03
8258266 IP-10 antibodies and their uses Shrikant Deshpande, Haichun Huang, Mohan Srinivasan, Josephine M. Cardarelli, Changyu Wang +4 more 2012-09-04